CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

RAAP Releases New Policy Study: "Follow the UPL"

Negative
AI Analysis

Summary

RAAP released a policy study titled 'Follow the UPL' examining state drug price caps, arguing that Upper Payment Limits fail to reduce patient costs and threaten access for rare disease patients. The study traces the pharmaceutical supply chain to illustrate the limitations of price cap policies.

Importance:2/10
Sentiment:
-0.30
policydrug pricingpatient accessrare disease

Read the original article

Published by PR Newswire Pharma on July 28, 2026 1:16 PM

Read Original